Keyphrases
Fenretinide
100%
Low-dose Tamoxifen
100%
Postmenopausal Women
100%
Breast Cancer Prevention
100%
Influenza
100%
Randomized Double-blind
100%
United Kingdom
100%
Symptom Onset
100%
High Risk
100%
A(H1N1)pdm09
100%
Transmission Dynamics
100%
Oseltamivir
100%
Mammographic Density
55%
Incubation Period
50%
Secondary Attack Rate
50%
Serial Interval
50%
Laboratory Confirmed Cases
50%
Epidemiological Characteristics
50%
Scotland
50%
Infectivity
50%
Travel Abroad
50%
Insulin-like
44%
Growth Factors
44%
Placebo
44%
Breast
33%
Endometrial Thickness
22%
Breast Neoplasms
22%
Clear Distinction
20%
PT1a
11%
Receptor Subtypes
11%
Intraepithelial Neoplasia
11%
Hazard Ratio
11%
Adverse Interactions
11%
Postmenopausal Breast Cancer
11%
Level Density
11%
Tumor Receptors
11%
Synergistic Interaction
11%
Breast Cancer
11%
Breast Cancer Risk
11%
Medicine and Dentistry
Premenopause
100%
Fenretinide
100%
Breast Cancer Prevention
100%
Low Drug Dose
100%
Tamoxifen
100%
Placebo
44%
Somatomedin C
44%
Breast Cancer
22%
Breast Tumor
22%
Hazard Ratio
11%
Neoplasm
11%
Biological Marker
11%
Arm
11%
Intraepithelial Neoplasia
11%
Receptor
11%
Cancer Risk
11%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Pharmacotherapy
100%
Fenretinide
100%
Tamoxifen
100%
Biological Marker
61%
Placebo
44%
Somatomedin C
44%
Monotherapy
25%
Anticonvulsive Agent
25%
Drug Resistance
25%
Breast Tumor
22%
Neoplasm
22%
Receptor
11%
Synergism
11%